News Hub | News Direct

All Industries


Article thumbnail News Release

MariMed closes acquisition of a dispensary in Illinois marking the company’s 5th in that state

MariMed Inc

MariMed CEO Jon Levine joined Steve Darling from Proactive to to share the Company’s significant developments, including its recent of Allgreens Dispensary, LLC, which closed on April 9, 2024. The acquisition enabled the Company to operate its 5th Thrive-branded dispensary in Illinois. It followed the recent opening of the Company’s processing facility in Mt. Vernon, Illinois, which enabled the Company to distribute its portfolio of top-selling brands throughout the high-growth state. Illinois surpassed $1.6 billion in adult-use cannabis sales last year, and MariMed looks to continue expanding there as current regulations in Illinois permit operators to own up to 10 dispensaries. In addition to its expansion efforts in Illinois, MariMed has acquired the assets of Our Community Wellness & Compassionate Care Center in Prince George's County, Maryland. This acquisition marks MariMed's second adult-use Thrive Wellness dispensary in Maryland, complementing its existing location in Annapolis. The Company is vertically integrated in Maryland, with a cultivation and processing facility in Hagerstown that distributes MariMed products state-wide. As a company dedicated to developing and distributing great brands and delivering an exceptional customer experience at its retail stores, these recent acquisitions underscore MariMed's commitment to strategic expansion and enhancing its footprint in key cannabis markets. Contact Details Proactive North America Proactive North America +1 604-688-8158 na-editorial@proactiveinvestors.com

April 24, 2024 02:01 PM Eastern Daylight Time

Video
Article thumbnail News Release

Nevis Brands announces major shots are now for sale in dozens if dispensaries in Missouri

Nevis Brands

Nevis Brands CEO John Kueber joined Steve Darling from Proactive to announce the successful completion of the initial production run of Major shots in Missouri through its licensee, Stash House Distro. This milestone marks the expansion of Nevis Brands' product offerings into the Missouri market, with three flavors of its 2-ounce Major shots—Fruit Punch, Blackberry Lemonade, and Blueberry—now available for sale. Nevis Brands has previously introduced these products in Washington and Ohio, achieving successful distribution. The Major shots are infused with 100mg of THC and leverage a proprietary formula of flavor and emulsion technology, enabling rapid onset effects in under 20 minutes with minimal cannabis taste. The products are now accessible to consumers in numerous dispensaries across Missouri, further solidifying Nevis Brands' presence in the cannabis beverage market. Additionally, Kueber shared news regarding the restructuring of the company's Promissory Note due to SoRSE Technology Corp., which was initially part of Nevis Brands' purchase of the SoRSE Technology business units "THC Essentials," including the Major brand. Under the revised terms of the agreement, Nevis Brands will pay USD $100,000 by April 30th, 2024, and proceed with periodic payments to retire the note principal by December 31, 2024. This strategic move reflects Nevis Brands' commitment to managing its financial obligations while continuing to expand its product portfolio and market presence. Contact Details Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com

April 24, 2024 01:57 PM Eastern Daylight Time

Video
Article thumbnail News Release

FRX Innovations Announces Delay of Annual Filings

FRX Innovations Inc

VANCOUVER, British Columbia – TheNewswire - April 24, 2024 – FRX Innovations Inc. (TSXV:FRXI) (FSE:W2A.F) (OTC:FRXIF) (“ FRX ” or the “ Company ”), a leader in eco-friendly flame-retardant solutions, announces that it anticipates the filing of its annual financial statements, management’s discussion and analysis and related officer certifications for the financial year ended December 31, 2023 (collectively, the “ Annual Filings ”) will be delayed beyond the required filing deadline under Parts 4 and 5 of National Instrument 51-102 – Continuous Disclosure Obligations and pursuant to National Instrument 52-109 – Certification of Disclosure in Issuer’s Annual and Interim Filings, that being April 29, 2024 (the “ Filing Deadline ”).   Due to extenuating circumstances relating to a member of FRX’s European finance team, the Company has determined that it will not be able to complete the audit and file the Annual Filings by the Filing Deadline. The Company intends to work closely with its auditor and expects to file the Annual Filings as soon as possible, and in any event no later than May 30, 2024.   The Company is providing this default announcement in accordance with National Policy 12-203 Management Cease Trade Orders (“ NP 12-203 ”). The Company has applied for a management cease trade order (the " MCTO ") by the Ontario Securities Commission. Until the Company files the Annual Filings, it will comply with the alternative information guidelines set out in NP 12-203. The guidelines, among other things, require the Company to issue bi-weekly default status reports by way of a news release so long as the Annual Filings have not been filed.   During the MCTO, the general investing public will continue to be able to trade in the Company's listed common shares. However, the Company's chief executive officer and chief financial officer will not be able to trade in the Company's shares.   About FRX   FRX is a global manufacturing company, producing a family of environmentally sustainable flame-retardant products that serve several large markets spanning textiles, electronics, automotive, electric vehicles (EV) and medical devices. FRX is led by a team of highly experienced business and technical professionals and is positioned to be a leader in the rapidly changing flame-retardant plastics and additives market in response to new legislation prohibiting Brominated and Perfluoro flame retardant chemicals.   Nofia® is a registered trademark of FRX. Nofia® products are manufactured at its manufacturing facility on the Port of Antwerp in Belgium, one of the world's largest chemical producing clusters. Nofia Polyphosphonates are produced using sustainable green chemistry principles such as a solvent-free production process, no waste by-products, and near 100% atom efficiency, and are both halogen and PFAS free. FRX's portfolio includes an extensive patent estate. FRX, at the forefront of the ESG movement to a greener future, has been the recipient of numerous awards, including the EPA's Environmental Merit Award, the Belgium Business Award for the Environment, and the Flanders Investment of the Year Award. FRX has also been recognized six times on the Global Cleantech 100 list. Cautionary Note Regarding Forward-Looking Statements and Reader Advisory   Certain statements contained in this news release, including, but not limited to, statements with respect to the date the Annual Filings will be filed, and the granting of an MCTO by the Ontario Securities Commission, among other things, and statements which may contain words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “estimates”, or similar expressions, and statements related to matters which are not historical facts, may constitute forward-looking information within the meaning of applicable securities laws. Such forward-looking statements, which reflect management’s expectations regarding the Company’s future growth, results of operations, performance, business prospects and opportunities, are based on certain factors and assumptions and involve known and unknown risks and uncertainties which may cause the actual results, performance, or achievements to be materially different from future results, performance, or achievements expressed or implied by such forward-looking statements.   These factors should be considered carefully, and readers should not place undue reliance on the Company’s forward- looking statements. The Company believes that the expectations reflected in the forward-looking statements contained in this news release and the documents incorporated by reference herein are reasonable based on information available to it, but no assurance can be given that these expectations will prove to be correct.   Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.    Contact Information:       FRX   Mark Lotz   CFO     +1 604-880-6546 mlotz@frxpolymers.com   Mike Goode CCO +1 765-838-9018 mgoode@frxpolymers.com FRX Investor Relations   Carl Desjardins +1 514-818-0447   Jean-Francois Meilleur +1 514-951-2730         Diane Wilson   +1 978-505-1275     ir@frx-innovations.com   FRX Media Inquiries   Joseph Grande     +1 413-684-2463 joe@jgrandecommunications.com

April 24, 2024 01:35 PM Eastern Daylight Time

Image
Article thumbnail News Release

Ocean Power Technologies Unveils Versatile New Generation of Buoy Systems

Ocean Power Technologies Inc

Ocean Power Technologies CEO Philipp Stratmann joined Steve Darling from Proactive to share exciting news about the launch of a new generation of buoy systems that mark significant advancements in the company's renewable energy technology. In an interview with Steve Darling from Proactive, Stratmann highlighted key features of these innovative buoy systems, which are designed to accommodate multiple renewable energy sources, including solar panels, wind turbines, and optionally, a wave power cartridge. One of the most notable improvements is the modular, common equipment system, which eliminates the need for externally moving parts. This design change not only enhances deployment flexibility worldwide but also reduces costs and prices associated with these systems. Additionally, it expands the deployable areas to include regions with variable wave activity, such as the Gulf of Mexico, and even areas where wave power is absent, such as river outlets. This increased versatility allows for broader average power production across different marine and freshwater environments. Stratmann also highlighted the significant reduction in R&D expenditures since November 2023, attributing this cost efficiency to the successful deployment and seasonal performance validations of the new buoy systems. He emphasized that these innovations are aligned with the growing global focus on zero-carbon solutions and the health of oceanic ecosystems, positioning Ocean Power Technologies as a key player in renewable energy conversations. Overall, the launch of these new buoy systems represents a significant milestone for Ocean Power Technologies and underscores its commitment to advancing renewable energy technology while addressing environmental challenges. Contact Details Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com

April 24, 2024 01:10 PM Eastern Daylight Time

Video
Article thumbnail News Release

NAFA Names the 2024 100 Best Fleets in the Americas at its Annual Institute & Expo

NAFA Fleet Management Association

NAFA Fleet Management Association (NAFA), the vehicle fleet industry’s largest membership association, today announced the 100 Best Fleets in the Americas for 2024. NAFA’s 100 Best Fleets in the Americas program recognizes peak-performing public and commercial fleet operations, as well as the Fleet Professional and Fleet Technician of the Year. The winners were announced this morning during NAFA’s annual Institute & Expo (I&E) in San Antonio. This contest aims to cultivate industry pride, enhance visibility within the fleet community, improve productivity and operational efficiency, and inspire individuals to pursue careers in fleet operations. Originally conceived by the late fleet industry advocate Tom Johnson, this contest is now in its 25th year running. “The 100 Best Fleets contest plays such an integral role in the NAFA community,” says Mike Camnetar, CAFM, NAFA Board President. “These awards showcase the outstanding achievements and leadership within our industry. We commend these fleets and individuals for their dedication to excellence and innovation, and we look forward to seeing what they accomplish in 2024.” The 2024 winners for each of the following categories: Best Public Fleet: Dakota County Fleet Management, MN Best Commercial Fleet: Essential Utilities Fleet Professional of the Year Award: Kenny Stimson, Carvana Fleet Technician of the Year Award: Curtis Mullins, City of Round Rock, TX The full list of the 2024 100 Best Fleets in the Americas can be found here https://www.nafa.org/100-best-fleets-2024/. The 100 Best Fleets Program Sponsors include Agile Fleet Management Solutions, AssetWorks, Fleet Worthy Solutions/Bestpass, Fuel Force, Geotab, Pure Forge Brakes, the NC Clean Energy Technology Center, RTA, Samsara and Toyota Fleet. NAFA is excited to host a 100 Best Webinar Series and Regional Roundtable events throughout 2024. Webinar attendees will have the opportunity to learn from the 100 Best fleet winners and leaders, discover the top five success trends for 2024 and understand what actions these top fleets have taken to become a 100 Best fleet. Attendees will walk away with initiatives and action steps they can immediately implement within their fleet. To register for this webinar series, visit: https://www.nafa.org/events/100-best-fleets-webinars/ To learn more about NAFA, visit: https://www.nafa.org/ NAFA Fleet Management Association is the membership organization for professionals who manage the mobility requirements of vehicle fleets that include commercial, public safety, trucks, and buses of all types and sizes, and a wide range of military and off-road equipment for corporations, governments, universities, utility fleets, and law enforcement in North America and across the globe. NAFA’s members are responsible for the specification, acquisition, maintenance, repair, fueling, risk management, and remarketing of more than 4.8 million vehicles that drive an estimated 84 billion miles each year. NAFA’s members control assets and services well above $122 billion each year. For more information, please visit www.nafa.org, and communicate with NAFA on LinkedIn, Facebook, and X. Contact Details Keaveny Hewitt +1 919-622-5276 khewitt@onwrdupwrd.com Company Website https://www.nafa.org/

April 24, 2024 12:44 PM Eastern Daylight Time

Article thumbnail News Release

The UK small cap re-rating opportunity - VT Downing Small & Mid-Cap Income Fund

Downing LLP

Josh McCathie, lead fund manager of the VT Downing Small & Mid-Cap Income Fund, tells Proactive's Stephen Gunnion he is optimistic about current market conditions, particularly in the UK. McCathie noted that challenges such as inflation and interest rates are subsiding, potentially shifting to support the market. He highlighted the significant opportunity in the UK's small and mid-cap sectors, citing that the FTSE 250 is trading at a 22% discount compared to its long-term average and at a steep discount relative to the FTSE 100—a scenario seen only twice in the past 20 years, historically followed by strong performance in small and mid-cap stocks. McCathie acknowledged threats from geopolitical tensions but emphasized the greater potential returns in the small and mid-cap space, pointing to expected earnings growth and dividend returns. He differentiated the VT Downing Small & Mid Cap Income Fund by its exclusive focus on small and mid-cap stocks, contrasting with other funds that focus on larger caps. He also discussed the overlooked dividend potential in smaller companies, suggesting that despite being perceived as growth-focused, they offer substantial dividend opportunities. Celebrating three years as the lead manager, McCathie reviewed the fund's performance, noting significant outperformance relative to other small-cap mandates and overall positive results despite some challenges in 2023. He advocated for investing in UK equity markets, citing the potential for strong returns and robust dividend yields as reasons for optimism. Contact Details Proactive UK Proactive UK +44 20 7989 0813 UKEditorial@proactiveinvestors.com

April 24, 2024 11:00 AM Eastern Daylight Time

Video
Article thumbnail News Release

Creo Medical says NHS case study reveals significant efficiencies from Speedboat technology

Creo Medical Group PLC

Creo Medical Group PLC (AIM:CREO) CEO Craig Gulliford discusses an NHS case study that showcases the efficacy of Creo's Speedboat technology. In an interview with Proactive's Stephen Gunnion, Gulliford discussed the case study, which was conducted by the NHS Supply Chain responsible for the procurement of devices and consumables worth approximately £4 billion. This study, which analysed 130 cases, demonstrated significant cost savings and clinical outcomes, with almost £700,000 saved and reductions in hospital stay times for patients, which potentially impacts surgical and endoscopy waiting lists significantly. Gulliford also outlined future plans involving routine guidance by NICE and ongoing partnerships with the NHS Supply Chain to further implement and leverage the technology across UK trusts. He emphasized the dual benefits of clinical excellence and cost savings. Additional updates from Gulliford included progress in other areas of the company, like advancements with robotics and polymeric technology, and significant regulatory developments. Overall, these initiatives are part of Creo’s strategy to expand its product range and increase utilisation of its technology not just in the UK but globally, he added. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

April 24, 2024 10:56 AM Eastern Daylight Time

Video
Article thumbnail News Release

Ilika chief executive Graeme Purdy discusses 2024 revenue growth and strategic milestones

Ilika PLC

Ilika PLC (AIM:IKA, OTCQX:ILIKF) chief executive Graeme Purdy discusses a trading update and the latest company milestones with Proactive's Stephen Gunnion. Purdy highlighted that Ilika's financial performance for the year ending in April is expected to be in line with projections, noting a significant revenue increase from £0.8 million the previous year to approximately £2 million. This growth is largely attributed to grant support for their Goliath development programme. He provided an update on the Goliath batteries, mentioning that they had reached a milestone in late 2023, which allowed them to start producing P1 prototypes for external evaluation. These prototypes are currently being tested, with results expected to be shared with partners soon. Additionally, Purdy touched on achieving lithium ion parity with their Goliath batteries, marking a significant technological advancement. He also discussed the progress with their Stereax product following a tech transfer and licence agreement with Cirtec in the USA, which is moving forward with the initial production line installed and operational. Purdy said investors can participate in a Q&A session with Ilika on 26 April at 11am BST on the Investor Meet Company (IMC) platform by registering here: https://www.investormeetcompany.com/ilika-plc/register-investor Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

April 24, 2024 10:54 AM Eastern Daylight Time

Video
Article thumbnail News Release

ANGLE partners with AstraZeneca in groundbreaking oncology contract

ANGLE PLC

ANGLE PLC chief executive Andrew Newland joins Proactive's Stephen Gunnion with news the company has entered a significant contract with AstraZeneca, marking its second major collaboration with a large pharmaceutical company. Newland, expressed enthusiasm about this development, noting the contract's potential to expand ANGLE's services in oncology trials. The initial phase of the contract is valued at £150,000, but it holds substantial potential due to the possibility of implementing a new assay in numerous cancer trials involving AstraZeneca. The scope of the collaboration includes the development of assays for examining proteins on cancer cells across multiple trials, with potential earnings of £2,000 per time point in over 460 trials. The contract also enables ANGLE to further validate and possibly expand its FDA approvals, positioning it uniquely as a provider of comprehensive diagnostic solutions internationally. Looking ahead, the successful execution of the contract could lead to extensive financial gains for ANGLE PLC, ranging into the tens or even hundreds of millions of pounds, particularly as AstraZeneca's trials progress and its drugs approach commercial launch. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

April 24, 2024 10:52 AM Eastern Daylight Time

Video
12345 ... 3512